Maze Therapeutics (MAZE)

Profile

Full Name

Maze Therapeutics, Inc.

Ticker Symbol

MAZE

Exchange

NASDAQ

Country

United States

IPO

January 31, 2025

Indexes

Not included

Employees

125

Key Details

Price

$8.10(-4.71%)

Market cap

$346.90M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$167.50M

Annual EPS

-

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 2, 25 Guggenheim
Buy
Feb 25, 25 Leerink Partners
Outperform
Feb 25, 25 JP Morgan
Overweight
Feb 25, 25 Guggenheim
Buy

Institutional Ownership

  • What is the ticker symbol for Maze Therapeutics?
  • Does Maze Therapeutics pay dividends?
  • What sector is Maze Therapeutics in?
  • What industry is Maze Therapeutics in?
  • What country is Maze Therapeutics based in?
  • When did Maze Therapeutics go public?
  • Is Maze Therapeutics in the S&P 500?
  • Is Maze Therapeutics in the NASDAQ 100?
  • Is Maze Therapeutics in the Dow Jones?
  • When was Maze Therapeutics's last earnings report?
  • When does Maze Therapeutics report earnings?
  • Should I buy Maze Therapeutics stock now?

What is the ticker symbol for Maze Therapeutics?

The ticker symbol for Maze Therapeutics is NASDAQ:MAZE

Does Maze Therapeutics pay dividends?

No, Maze Therapeutics does not pay dividends

What sector is Maze Therapeutics in?

Maze Therapeutics is in the Healthcare sector

What industry is Maze Therapeutics in?

Maze Therapeutics is in the Biotechnology industry

What country is Maze Therapeutics based in?

Maze Therapeutics is headquartered in United States

When did Maze Therapeutics go public?

Maze Therapeutics's initial public offering (IPO) was on January 31, 2025

Is Maze Therapeutics in the S&P 500?

No, Maze Therapeutics is not included in the S&P 500 index

Is Maze Therapeutics in the NASDAQ 100?

No, Maze Therapeutics is not included in the NASDAQ 100 index

Is Maze Therapeutics in the Dow Jones?

No, Maze Therapeutics is not included in the Dow Jones index

When was Maze Therapeutics's last earnings report?

Maze Therapeutics's most recent earnings report was on Mar 31, 2025

When does Maze Therapeutics report earnings?

The next expected earnings date for Maze Therapeutics is May 30, 2025

Should I buy Maze Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page